1. Home
  2. ADMA vs QTWO Comparison

ADMA vs QTWO Comparison

Compare ADMA & QTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • QTWO
  • Stock Information
  • Founded
  • ADMA 2004
  • QTWO 2004
  • Country
  • ADMA United States
  • QTWO United States
  • Employees
  • ADMA N/A
  • QTWO N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • QTWO Computer Software: Prepackaged Software
  • Sector
  • ADMA Health Care
  • QTWO Technology
  • Exchange
  • ADMA Nasdaq
  • QTWO Nasdaq
  • Market Cap
  • ADMA 5.3B
  • QTWO 4.8B
  • IPO Year
  • ADMA N/A
  • QTWO 2014
  • Fundamental
  • Price
  • ADMA $21.18
  • QTWO $106.42
  • Analyst Decision
  • ADMA Strong Buy
  • QTWO Buy
  • Analyst Count
  • ADMA 4
  • QTWO 16
  • Target Price
  • ADMA $21.25
  • QTWO $89.50
  • AVG Volume (30 Days)
  • ADMA 3.9M
  • QTWO 746.5K
  • Earning Date
  • ADMA 11-07-2024
  • QTWO 11-06-2024
  • Dividend Yield
  • ADMA N/A
  • QTWO N/A
  • EPS Growth
  • ADMA N/A
  • QTWO N/A
  • EPS
  • ADMA 0.28
  • QTWO N/A
  • Revenue
  • ADMA $382,809,000.00
  • QTWO $675,537,000.00
  • Revenue This Year
  • ADMA $60.41
  • QTWO $13.21
  • Revenue Next Year
  • ADMA $13.09
  • QTWO $11.34
  • P/E Ratio
  • ADMA $75.56
  • QTWO N/A
  • Revenue Growth
  • ADMA 63.39
  • QTWO 10.92
  • 52 Week Low
  • ADMA $3.60
  • QTWO $34.59
  • 52 Week High
  • ADMA $23.64
  • QTWO $106.52
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 59.66
  • QTWO 75.44
  • Support Level
  • ADMA $18.90
  • QTWO $95.31
  • Resistance Level
  • ADMA $21.70
  • QTWO $104.50
  • Average True Range (ATR)
  • ADMA 1.13
  • QTWO 3.93
  • MACD
  • ADMA 0.08
  • QTWO 0.50
  • Stochastic Oscillator
  • ADMA 51.48
  • QTWO 99.54

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About QTWO Q2 Holdings Inc.

Q2 Holdings Inc. is a provider of cloud-based virtual banking solutions for regional financial institutions to deliver mobile banking services to retail and commercial end-users who wish to bank anywhere and anytime. Its solutions operate on an integrated tablet-first platform which provides financial institutions a comprehensive view of account holder activity and meets the regulatory and security requirements applicable to the industry. The firm generates revenue from subscription-based arrangements for software offerings. A large majority of the firm's revenue is generated in the United States.

Share on Social Networks: